The Biden administration has announced a vaccine mandate, the FDA delayed regulatory decisions on some of the e-cigarette industry's biggest players, and the CEO of Biogen, the pharmaceutical company that manufactures Alzheimer's drug, Aduhelm, has released a statement on the slow start of the company's Alzheimer's drug rollout.